Dr NISHI PATEL | Neuroscience | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Dr NISHI PATEL | Neuroscience | Best Researcher Award

Dr NISHI PATEL | Neuroscience | Best Researcher Award   🏆

Research Scholar at Bhagwan Mahavir University, Surat , India🎓

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease 🧠. With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinson’s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional Profile 

  • Google Scholar 

Education 🎓

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience 🏢

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors 🏆

While specific awards are not mentioned, Dr. Patel’s numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus 🔍

Dr. Patel’s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinson’s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications : 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum – An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinson’s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153

 

Mr Di Wu | Problem Solving | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Mr Di Wu | Problem Solving | Best Researcher Award

Mr Di Wu | Problem Solving | Best Researcher Award 🏆


MD/PhD Candidate at  Saint Louis University School of Medicine,United States🎓

Di (Andy) Wu is a doctoral candidate in Molecular Microbiology and Immunology at Saint Louis University School of Medicine, expected to earn his Ph.D. in Fall 2024. He also pursues his M.D. with an expected graduation in Spring 2027. Wu holds a B.S. in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign, where he graduated Summa Cum Laude. His research interests include osteoimmunology, T cell biology, and systems biology, with significant contributions to understanding bone quality and immune responses in osteoporosis. Wu has published several notable papers and has presented his research at multiple conferences. As an active mentor and leader in the American Physician Scientists Association, he is dedicated to fostering the next generation of scientists. Wu also engages in community service, facilitating support groups for families affected by mental health issues through the National Alliance on Mental Illness (NAMI). His commitment to research and community makes him a promising figure in the biomedical sciences.

Professional Profile 

Education 🎓

Di (Andy) Wu is currently a doctoral candidate in Molecular Microbiology and Immunology at Saint Louis University School of Medicine, expecting to complete his Ph.D. in Fall 2024. He is also pursuing his Doctor of Medicine (MD) degree at the same institution, which he expects to receive in Spring 2027. Andy earned his Bachelor of Science in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign in May 2017, where he graduated with high honors.

Work Experience 🏢

Andy has extensive research experience, serving as a Doctoral Candidate in the Department of Molecular Microbiology and Immunology at Saint Louis University since 2019. He has conducted significant research on the effects of estrogen loss on bone fragility and the therapeutic potential of pulsed RANKL in osteoporosis. Prior to this, he was a Summer Medical Student Research Assistant in 2018, where he worked with infectious agents, specifically the Rift Valley Fever Virus, and tested compounds for their efficacy against the virus. His undergraduate research at the University of Illinois involved studying the defense mechanisms of Salmonella Typhimurium against oxidative stress.

Skills 🔬

Andy possesses a strong background in molecular microbiology and immunology, with specific expertise in T cell biology, osteoimmunology, and systems biology. He has developed technical skills in handling BSL3 infectious agents, conducting in vitro experiments, and utilizing various research methodologies to investigate complex biological questions. His mentoring and leadership skills are demonstrated through his roles in various academic organizations.

Awards and Honors 🏆

Throughout his academic career, Andy has received several prestigious awards, including graduating Summa Cum Laude from the University of Illinois, recognition on the Bronze Tablet for ranking in the top 3% of his graduating class, and achieving the Highest Distinction in Research and Academia for his senior thesis. These honors reflect his commitment to academic excellence and research contributions.

Membership 🌍

Andy is an active member of several professional organizations, including the American Physician Scientists Association (APSA), the Asian Pacific American Medical Student Association (APAMSA), and the American Society for Microbiology (ASM). His involvement in these groups showcases his dedication to the scientific community and his interest in promoting collaboration among peers.

Teaching Experience 👨‍🏫

As a Graduate Research Assistant, Andy has mentored undergraduate and medical students in their summer research internships, providing guidance and support in their scientific endeavors. Additionally, he serves as a peer mentor for students considering careers in medicine and science, sharing his experiences to help them navigate their educational paths.

Research Focus 🔍

Andy Wu’s research interests center on osteoimmunology, T cell biology, and bone quality, with a particular focus on understanding the mechanisms underlying bone fragility and postmenopausal osteoporosis. His work aims to explore the interplay between immune responses and bone health, contributing to the development of potential therapeutic strategies for bone-related diseases.

Publications : 

  • Memory T-Cells Contribute to Calcium Release from Bones during Lactation in Mice
    Year: 2024
    Journal: Nutrients
    DOI: 10.3390/nu16193289
  • T-Cell Mediated Inflammation in Postmenopausal Osteoporosis
    Year: 2021
    Journal: Frontiers in Immunology
    DOI: 10.3389/fimmu.2021.687551

 

Dr Alexander Chernov| neuro-oncology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Dr Alexander Chernov| neuro-oncology | Best Researcher Award

Dr Alexander Chernov| neuro-oncology | Best Researcher Award 🏆


DR at Institute of Experimental Medicine🎓

Dr. Alexander Nikolaevich Chernov is a PhD and Senior Researcher at the World-Class Research Centre “Center for Personalized Medicine” at the Institute of Experimental Medicine, Saint Petersburg, Russia 🧬. With an impressive portfolio of over 80 scientific papers, six patents, and ongoing collaborations with international institutions, Dr. Chernov has made significant contributions in the fields of neuroimmunooncology, glioblastoma research, and the study of nerve growth factors. In 2021, he defended his PhD thesis on the effects of nerve growth factor and immune peptides on brain tumor cells, and in 2022-2023, he completed a postdoctoral fellowship at Ben-Gurion University, Israel 🇮🇱.

 

Professional Profile 

Education 🎓

Dr. Chernov holds a PhD with expertise in neurobiology, focusing on brain tumors and chemotherapy. He has a solid foundation in biochemistry, serving as an assistant professor at Saint Petersburg State Pediatric Medical University 🎓.

Work Experience 🏢

Dr. Chernov’s extensive research includes working as a senior researcher at multiple prestigious institutions in Russia, including the D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology. He has also been involved in numerous consultancy and industry projects across nine different sectors.

Awards and Honors 🏆

Dr. Chernov has earned recognition for his exceptional work in brain tumor research, including the nomination for the Best Researcher Award for his article on glioblastoma sensitivity to antimicrobial peptides.

👨‍🏫 Teaching & Memberships🌍

Dr. Chernov is a dedicated educator, currently teaching biochemistry at Saint Petersburg State Pediatric Medical University. He is a member of the Belarusian Society of Physiologists, contributing to his international scientific community .

Research Focus 🔍

His main research areas include glioblastoma, nerve growth factors, chemotherapy, and antimicrobial peptides such as LL-37 and PG-1 🧠. Dr. Chernov’s groundbreaking work has shown how these peptides, in combination with chemotherapy drugs, can predict overall survival in patients with glioblastoma. His research has also demonstrated the effects of these combinations on the inhibition of glioma cell clonogenicity and migration.

Publications : 

 

  • “Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors”
    • Medicinal Chemistry, 2012
  • “Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier”
    • Pharmaceutics, 2011
  • “Biological activity of silver-doped DLC films”
    • Diamond and Related Materials, 2009
  • “Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome”
    • Frontiers in Genetics, 2020
  • “Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients”
    • Frontiers in Immunology, 2021
  • “The phenomenon of multidrug resistance in glioblastomas”
    • Hematology/Oncology and Stem Cell Therapy, 2021
  • “Genetic risk factors for the development of COVID-19 coronavirus infection”
    • Russian Journal of Genetics, 2021
  • “Pharmacogenetic Study of the Impact of ABCB1 Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients”
    • Pharmaceutics, 2022
  • “Pathophysiological mechanisms of autism in children”
    • Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova, 2020
  • “Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration”
    • Molecules, 2022

Prof Dmitry Beloyartsev | Problem Solving | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Prof Dmitry Beloyartsev | Problem Solving | Best Researcher Award

Prof Dmitry Beloyartsev | Problem Solving | Best Researcher Award  🏆


Chief Researcher at Vascular Surgery Department, A. V. Vishnevsky National Medical Research Center of Surgery🎓

Belozyartsev Dmitry Felixovich, is a renowned vascular surgeon and academician with an illustrious career in cardiovascular surgery. He has been a key figure at the A.V. Vishnevsky Institute of Surgery and the Russian Medical Academy of Postgraduate Education (RMAPO), where he continues to influence the field of vascular surgery through his clinical work, teaching, and research.

Professional Profile 

  • Google Scholar 

Education 🎓

Dmitry Belozyartsev graduated in 1986 from the Faculty of Medicine at the II Moscow State Medical Institute, named after N.I. Pirogov. Following this, he pursued advanced medical education, completing a clinical residency in surgery from 1986 to 1988 and a clinical postgraduate program in cardiovascular surgery at the A.V. Vishnevsky Institute of Surgery between 1988 and 1991. His early academic achievements laid the foundation for his expertise in cardiovascular and vascular surgery.

Work Experience 🏢

Belozyartsev began his professional career as a vascular surgeon at the A.V. Vishnevsky Institute of Surgery after completing his postgraduate studies in 1991, a role he holds to this day. His academic career progressed when he was appointed as an assistant professor at RMAPO in 2005. In 2009, he was promoted to the rank of professor at the Department of Angiology, X-ray Endovascular, and Vascular Surgery. His combined clinical and academic roles have allowed him to make significant contributions to the field.

Skills 🔬

Belozyartsev has a broad range of specialized skills in the field of vascular surgery. His expertise includes surgery on the branches of the aortic arch, advanced ultrasound diagnostics for vascular diseases affecting the brain, thoracic aortic surgery, and innovative endovascular surgery techniques. He also has experience in the surgical treatment of rare vascular conditions, such as popliteal artery entrapment syndrome. His proficiency in both surgical and diagnostic methods makes him a leading figure in his field.

Awards and Honors 🏆

Throughout his career, Belozyartsev  has earned several academic and professional honors. In 1991, he defended his Ph.D. thesis on “Recanalization with excimer laser radiation and dilation in occlusive arterial lesions.” He continued to advance his research, defending his doctoral dissertation in 1999 on “Results of surgical treatment of proximal lesions of the branches of the aortic arch in atherosclerosis.” He was awarded the academic title of Associate Professor in 2014, and in 2018, he achieved the rank of Full Professor, reflecting his sustained contributions to the field.

Membership 🌍

Belozyartsev is an active member of both national and international professional organizations. He is a long-standing member of the Russian Society of Angiologists and Vascular Surgeons, as well as the European Society for Vascular and Endovascular Surgery. These memberships enable him to stay at the forefront of global advances in vascular surgery and collaborate with leading experts worldwide.

Teaching Experience 👨‍🏫

In addition to his clinical and research roles, Belozyartsev has extensive teaching experience. He began teaching as an assistant professor in 2005, and since 2009, he has served as a professor at the Department of Angiology at RMAPO. His role in training future vascular surgeons is highly regarded, and his students benefit from his vast clinical experience and cutting-edge knowledge in vascular surgery and endovascular techniques.

Research Focus 🔍

Belozyartsev’s research focuses on several key areas within vascular surgery. These include the surgical treatment of branches of the aortic arch, the use of ultrasound diagnostics for brain vascular diseases, and innovations in thoracic aortic surgery. Additionally, he has contributed to national guidelines on the treatment of brachiocephalic artery diseases. As the author of over 130 published works, his research has helped advance both clinical and academic understanding of complex vascular conditions.

 

Publications : 

 

Prof Dr Leidy Azucena Ramírez Fráncel | functional ecology | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Prof Dr Leidy Azucena Ramírez Fráncel | functional ecology | Best Researcher Award

 Prof Dr Leidy Azucena Ramírez Fráncel | functional ecology | Best Researcher Award 🏆


Academician/Research Scholar at  Professor and researcher🎓

Leidy Azucena Ramírez-Fráncel is a distinguished biologist from Colombia, with expertise in the study of insectivorous bats. She holds a PhD in Biological Sciences and currently serves as a professor and researcher at the University of Ibagué. As a Minciencias Fellow, her work significantly contributes to the conservation of tropical dry forests, focusing on the ecological role of bats in pest control.

Professional Profile 

Education 🎓

Leidy holds a Bachelor’s degree in Natural Sciences, a Master’s, and a PhD in Biological Sciences, all from the University of Tolima. Her doctoral thesis was recognized for its excellence, particularly in its examination of ecomorphological traits of bats.

Work Experience 🏢

She is a postdoctoral researcher and professor at the University of Ibagué. Leidy’s professional journey includes significant contributions to understanding bat ecology, particularly how their cranial morphology and bite force allow them to adapt to different prey in tropical ecosystems.

Skills 🔬

Her skill set includes expertise in ecomorphology, field research, biological control, ecological conservation, and statistical analysis related to biodiversity. She is also proficient in scientific writing and publishing.

Awards and Honors 🏆

He has been recognized for his innovative contributions to medical biotechnology and has received multiple grants and funding for his research projects, underlining his reputation as a leader in the field.

Membership 🌍

Leidy is associated with several scientific communities, contributing her expertise in biological sciences and conservation efforts. She actively collaborates with Minciencias, a prestigious Colombian research network.

Teaching Experience 👨‍🏫

As a professor at the University of Ibagué, Leidy teaches courses in biological sciences, guiding students in topics like biodiversity, ecology, and conservation. Her hands-on teaching style incorporates fieldwork, mentoring young researchers, and promoting sustainable conservation practices.

Research Focus 🔍

Her research primarily revolves around the cranial morphology, bite force, and diet of insectivorous bats from the Colombian tropical dry forest. Leidy has published extensively on how these traits allow bats to feed on prey of varying hardness, emphasizing their role in pest control and their ecological importance in maintaining the balance of vulnerable ecosystems.

 

 

Publications : 

  • Bats and their vital ecosystem services: a global review
    2022 – Integrative Zoology, 17(1), 2-23
  • Mamíferos en relictos de bosque seco tropical del Tolima, Colombia
    2015 – Mastozoología Neotropical, 22(1), 11-21
  • Mamíferos del departamento del Tolima: distribución y estado de conservación
    2019 – Revista UDCA Actualidad & Divulgación Científica, 22(2)
  • Foraging strategies, craniodental traits, and interaction in the bite force of Neotropical frugivorous bats (Phyllostomidae: Stenodermatinae)
    2021 – Ecology and Evolution, 11(20), 13756-13772
  • Using MaxEnt modeling to predict the potential distribution of Platyrrhinus ismaeli (Phyllostomidae)
    2020 – Therya, 11(2), 203-212
  • Human-bat interactions in central Colombia: regional perceptions of a worldwide fragile life zone
    2021 – Ethnobiology and Conservation, 10, 1-18
  • Consumo de plantas pioneras por murciélagos frugívoros en un fragmento de bosque seco tropical (Colombia)
    2019 – Ciencia en Desarrollo, 10(2), 33-41
  • Bats and their vital ecosystem services: a global review
    2022 – Integrative Zoology, 17(1), 2-23
  • Skull morphology, bite force, and diet in insectivorous bats from tropical dry forests in Colombia
    2021 – Biology, 10(10), 1012
  • Potential distribution of Sphaeronycteris toxophyllum in Colombia and new record
    2018 – Therya, 9(3), 255-260

Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award

Dr YUKSEL ÇETİN | Functional Biomaterials | Best Researcher Award 🏆

Chief Researcher at The Scientific and Technological Research Council (TUBITAK), Marmara Research Center (MAM)🎓

Dr. Yüksel Çetin is the Chief Researcher at the Life Sciences, Medical Biotechnology Unit of TUBITAK’s Marmara Research Centre, Turkey. He earned his PhD in Food Science and Technology from the University of Nebraska-Lincoln, with a minor in Toxicology. His postdoctoral work focused on pulmonary disease pathogenesis through the FP 6 PULMONET project. Yüksel specializes in in vivo and in vitro toxicology, studying novel drugs, biomaterials, and nanoparticles. He leads several funded projects, including NANOBIO4CAN for cancer therapies and the development of 3D cardiac patches. His commitment to innovation and safety in biotechnology highlights his significant contributions to the field.

 

Professional Profile 

Education 🎓

Yüksel Çetin earned his PhD in Food Science and Technology from the University of Nebraska-Lincoln, USA, with a minor in Toxicology from the Toxicology Centre for Environmental Toxicology at the Eppley Institute for Research in Cancer and Allied Diseases. His postdoctoral research focused on the pathogenesis of pulmonary disease through the FP 6 PULMONET Marie Curie Project at the European Commission’s Joint Research Centre.

Work Experience 🏢

Currently serving as Chief Researcher at the Life Sciences, Medical Biotechnology Unit of the Scientific & Technological Research Council of Turkey (TUBITAK) at the Marmara Research Centre, Yüksel has held multiple leadership roles in various research projects, overseeing significant budgets and collaborative efforts aimed at advancing medical biotechnology and toxicology.

Skills 🔬

Yüksel possesses extensive expertise in in vivo and in vitro toxicology, molecular mechanisms of drugs, biomaterials, and medical devices. His proficiency in three-dimensional bioprinting technology and nanoparticle research is complemented by a robust background in evaluating the pathogenicity of xenobiotics.

Awards and Honors 🏆

He has been recognized for his innovative contributions to medical biotechnology and has received multiple grants and funding for his research projects, underlining his reputation as a leader in the field.

Membership 🌍

Yüksel is an active member of various scientific organizations and advisory boards, including involvement in Horizon 2020 projects focused on nanotechnology and safety assessments, emphasizing his commitment to advancing scientific research and innovation.

Teaching Experience 👨‍🏫

With a wealth of knowledge, Yüksel has shared his expertise through teaching roles at various academic institutions, focusing on topics related to food science, toxicology, and medical biotechnology, mentoring the next generation of scientists.

Research Focus 🔍

His research primarily investigates the toxicological effects of novel drugs, biomaterials, and nanoparticles, as well as the development of innovative therapeutic approaches for cancer treatment. Yüksel’s projects encompass antiviral research, tissue regeneration, and vaccine development, demonstrating his dedication to impactful scientific advancements.

 

Publications : 

  • Cytotoxicity of Fusarium mycotoxins to mammalian cell cultures as determined by the MTT bioassay
    Year: 2005
    Journal: Food and Chemical Toxicology
  • In vitro evaluation of the toxicity induced by nickel soluble and particulate forms in human airway epithelial cells
    Year: 2011
    Journal: Toxicology in vitro
  • Evaluation of reduced toxicity of zearalenone by extrusion processing as measured by the MTT cell proliferation assay
    Year: 2005
    Journal: Journal of Agricultural and Food Chemistry
  • Characterisation of cadmium chloride induced molecular and functional alterations in airway epithelial cells
    Year: 2009
    Journal: Cellular Physiology and Biochemistry
  • Evaluation of the molecular mechanisms of a palladium (II) saccharinate complex with terpyridine as an anticancer agent
    Year: 2014
    Journal: Anti-Cancer Drugs
  • A novel system to study the impact of epithelial barriers on cellular metabolism
    Year: 2000
    Journal: Annals of Biomedical Engineering
  • Confirmation of reduced toxicity of deoxynivalenol in extrusion-processed corn grits by the MTT bioassay
    Year: 2006
    Journal: Journal of Agricultural and Food Chemistry
  • The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
    Year: 2022
    Journal: Molecular Therapy
  • The Development of Novel Approaches to the Identification of Chemical and Protein Respiratory Allergens: Progress made from the Conclusions and Recommendations of ECVAM Workshop 60
    Year: 2008
    Journal: Alternatives to Laboratory Animals
  • Fabrication of a dual-drug-loaded smart niosome-g-chitosan polymeric platform for lung cancer treatment
    Year: 2023
    Journal: Polymers
  • Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity
    Year: 2022
    Journal: Phytochemical Analysis
  • A palladium (II)–saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft model
    Year: 2017
    Journal: Anti-Cancer Drugs

Prof Dr ALI Al KAISSI | Congenital Bone disorders | Excellence in Research

Posted on by sciencefatherLeave a Comment on Prof Dr ALI Al KAISSI | Congenital Bone disorders | Excellence in Research

 Prof Dr ALI Al KAISSI | Congenital Bone disorders | Excellence in Research 🏆

Honorary Prof at Ilizarov Institute, National Medical Re, Austria🎓

Dr. Ali Al Kaissi is an accomplished medical professional and researcher, known for his extensive work in pediatric orthopedics and genetic syndromes. Born in Baghdad, Iraq, Dr. Al Kaissi currently holds Austrian and Iraqi citizenship. He serves as a Visiting Professor at the National Medical Research Center for Traumatology and Orthopedics, Ilizarov, in Kurgan, Russia. His career spans decades of clinical and academic expertise, with numerous international collaborations and contributions to the medical field.

 

Professional Profile 

🎓 Education

Dr. Al Kaissi holds a Doctor of Medicine and Science (DSc – Honorary) from the Turner Scientific Research Institute, Russia (2017). He earned an MSc in Pediatric Developmental Abnormalities from the University of Warwick, UK (1988-1990) and completed his MD at the Faculty of Medicine, Azhar University, Cairo, Egypt (1972-1978). He also obtained a Certificate in Pediatrics from the University of Warwick, UK (1987-1988).

💼 Work Experience

Dr. Al Kaissi has served as a Consultant and Scientist at the Pediatric Department of the Orthopedic Hospital of Speising in Vienna, Austria, since 2005. He was also a Consultant at the Ludwig-Boltzmann Institute of Osteology, Vienna (2005-2021). Prior to that, he worked as a Consultant and Clinical Researcher at the Department of Pediatric Orthopedics at the Children’s Hospital in Tunis, Tunisia (1993-2005), and held various roles as Resident and Senior House Officer in Baghdad, Iraq (1980-1986).

🏆 Awards and Honors

He was awarded an Honorary Doctorate from the Pediatric Orthopedic Institute in Saint Petersburg, Russia (2017) and received the prestigious Russian Golden Medal for Distinguished Clinicians the same year. In 2019, he was honored with the Silver Dagistani Sword for Distinguished Clinicians and Researchers.

🔬 Research Focus

Dr. Al Kaissi’s research has led to groundbreaking discoveries, including the identification of Al Kaissi Syndrome (OMIM 617694). He has contributed significantly to the research on 3MC syndrome and Desbuquois dysplasia. His primary focus lies in pediatric musculoskeletal disorders, skeletal dysplasia, and genetic malformations, with numerous publications in the field of medical genetics.

📜 Teaching Experience

He has been an Honorary Professor at the Pediatric Orthopedic Institute in Saint Petersburg, Russia, since 2010 and a Visiting Professor at the National Medical Research Center for Traumatology and Orthopedics, Ilizarov, Kurgan, Russia, since 2020.

🌍 Memberships

Dr. Al Kaissi is a member of the Royal Society of Medicine (UK), the Austrian Medical Council, the Tunisian Medical Association, and the Science Advisory Board (USA).

📚 International Collaborations

Dr. Al Kaissi maintains extensive collaborations with institutions in Russia, the UK, Canada, and Australia. He has co-authored numerous papers with Prof. Michael Baraitser (UK) and Prof. Kazimierz Kozlowski (Australia), focusing on genetic disorders and pediatric orthopedics.

 

Publications : 

  • The Orthopedic Strategy for Patients with Larsen Syndrome
    Year: 2024
    Journal: Preprint
    DOI: 10.20944/preprints202407.2467.v1
  • Radiographic and Tomographic Study of the Cranial Bones in Children with the Idiopathic Type of West Syndrome
    Year: 2024
    Journal: Pediatric Reports
    DOI: 10.3390/pediatric16020035
  • Radiographic and Tomographic Study of the Cranial Bones in Children with the Idiopathic Type of West Syndrome
    Year: 2023
    Journal: Preprint
    DOI: 10.20944/preprints202312.0512.v1
  • Cutaneous, Cranial, and Skeletal Defects in Children and Adults with Focal Dermal Hypoplasia
    Year: 2023
    Journal: Children
    DOI: 10.3390/children10101715
  • Meticulous and Early Understanding of Congenital Cranial Defects Can Save Lives
    Year: 2023
    Journal: Children
    DOI: 10.3390/children10071240
  • The Tomographic Study and the Phenotype of Wormian Bones
    Year: 2023
    Journal: Diagnostics
    DOI: 10.3390/diagnostics13050874
  • Craniofacial Malformations as Fundamental Diagnostic Tools in Syndromic Entities
    Year: 2022
    Journal: Diagnostics
    DOI: 10.3390/diagnostics12102375
  • Infantile Systemic Hyalinosis: Variable Grades of Severity
    Year: 2021
    Journal: African Journal of Paediatric Surgery (AJPS)
    PMID: 34341308 | DOI: 10.4103/ajps.ajps_162_20
  • Upper Limb Pathology in Children with Mucopolysaccharidoses
    Year: 2021
    Journal: Traumatology and Orthopedics of Russia
    DOI: 10.21823/2311-2905-2021-27-2-34-43
  • Clinical Phenotype and Bone Biopsy Characteristics in a Child with Proteus Syndrome
    Year: 2021
    Journal: Calcified Tissue International
    PMID: 34003338 | DOI: 10.1007/s00223-021-00862-z

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award 🏆

Division of Diabetes and Nutrition at RARiS, Tohoku University, Japan
🎓

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional Profile 

📚 Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

🎖️ Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications : 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences

Prof Xiaofeng Li | Business Management | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Prof Xiaofeng Li | Business Management | Best Researcher Award

Prof Xiaofeng Li | Business Management | Best Researcher Award 🏆

Professor at Business School of Sichuan University,China 🎓

📚 Xiaofeng Li is a highly accomplished professor at the Business School of Sichuan University, specializing in entrepreneurship, innovation, and project management. With a PhD in Business Management, obtained in June 2005, Xiaofeng has made significant contributions to academic research and the entrepreneurial education landscape in China. He has actively participated in the promotion of entrepreneurship and innovation education, collaborating with institutions like the Sichuan Innovation and Entrepreneurship Center. His research has been widely cited, and he has published extensively on various entrepreneurial topics.

 

Professional Profile 

Education

Xiaofeng Li holds a PhD in Business Management, which he earned in June 2005. His educational background laid the foundation for his focus on entrepreneurship and innovation. His academic career advanced further when he was appointed as a professor at Sichuan University in July 2011.

Work Experience

Xiaofeng’s career is highlighted by his roles in academia and consultancy. As a professor at Sichuan University, he has overseen 33 research projects and 17 consultancy or industry-related initiatives. In 2017, he was recognized as one of China’s “Ten Thousand Outstanding Innovation and Entrepreneurship Mentor Talents”. He has contributed to significant scientific progress in Sichuan Province, winning several prestigious awards.

Skills 

Xiaofeng Li possesses a rich skill set in entrepreneurial behavior analysis, project management, risk assessment, and neural network algorithm development. His expertise extends to building dynamic risk prevention mechanisms tailored to China’s entrepreneurial environment. He is also proficient in publishing research and securing citations, with over 290 citations for his work.

Awards & Honors

Throughout his career, Xiaofeng has received numerous accolades, including:

  • Second prize in National Teaching Achievements
  • Second prize in National Outstanding Achievements in Humanities
  • Second prize in Scientific and Technological Progress in Sichuan Province
  • Third prize in Philosophy and Social Sciences in Sichuan Province

 Membership 

Xiaofeng holds several leadership roles, including:

  • Executive Director and Secretary General of Sichuan Industrial and Applied Mathematics Society
  • Vice Chairman of Sichuan Innovation and Entrepreneurship Education Guidance Committee
  • Member of the Expert Committee of Sichuan Technology, Economy, and Management Modernization Research Association

Teaching Experience

Xiaofeng is a passionate educator, contributing to the development of the entrepreneurship education system for college students. His work has been recognized by awards, and he has published books on topics such as entrepreneurial risks and student support systems. He regularly teaches and mentors students in the field of innovation management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications : 

  • Chinese Family Farm Business Risk Assessment Using a Hierarchical Hesitant Fuzzy Linguistic Model
    🗓️ 2024
    📰 Mathematics
    📄 12(14), 2216
    🚜💼📊
  • Risk analysis and selection decision model of family farm entrepreneurial projects
    🗓️ 2023
    📰 ACM International Conference Proceeding Series
    📄 pp. 756–760
    📉👩‍🌾🏢
  • Establishment and Application of BP Neural Network Model for Quality Assessment of Innovation and Entrepreneurship Education in Colleges and Universities
    🗓️ 2023
    📰 2023 4th International Conference on Information Science and Education, ICISE-IE
    📄 pp. 258–263
    🧠🏫💡
  • A Review of Model-Based Scenario Analysis of Poverty for Informing Sustainability
    🗓️ 2022
    📰 Environmental Science and Policy
    📄 137, pp. 336–348
    🌍💡📉
  • The Establishment of CW-EME Model for Competency Evaluation of International Accounting Talent
    🗓️ 2022
    📰 Proceedings – 2022 3rd International Conference on Education, Knowledge and Information Management, ICEKIM
    📄 pp. 502–508
    🌐💼📊
  • Establishment and Application of G1-CRITIC-MEEM Model for Evaluation of Utilization Efficiency of Power Grid Assets
    🗓️ 2022
    📰 Proceedings of SPIE – The International Society for Optical Engineering
    📄 12500, 1250035
    ⚡🔋📈
  • The Construction of Global Competency Training Model and Evaluation Index System for College Students
    🗓️ 2022
    📰 Lecture Notes on Data Engineering and Communications Technologies
    📄 145, pp. 427–441
    🌍🎓📘
  • Research on Risk Hierarchical Structure of High-Tech Startups Based on DEMATEL-ISM Model
    🗓️ 2022
    📰 Lecture Notes on Data Engineering and Communications Technologies
    📄 144, pp. 17–29
    🚀🖥️📊
  • Establishment and Application of the CW-MEEM Model for Post-Evaluation of Power Grid Construction Projects
    🗓️ 2022
    📰 2022 7th Asia Conference on Power and Electrical Engineering, ACPEE
    📄 pp. 1352–1357
    🔋🏗️📊
  • Investment Capacity Prediction of Power Grid Enterprise Based on Self-organizing Data Mining Technology
    🗓️ 2021
    📰 ACM International Conference Proceeding Series
    📄 pp. 999–1004
    🏢⚡📊

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAward  🏆

Principal Scientist of Cognitive Health at DSM-Firmenich, RD Innovation
Switzerland🎓

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional Profile 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

Skills 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

 Membership 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications : 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    🧠 International Journal of Molecular Sciences – 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    🧬 Cell – 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    🔬 The Journal of Neuroscience – 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    🧩 Biological Psychiatry – 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    🧠 Neuron – 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    🧠 Current Opinion in Neurobiology – 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    🐁 Neurobiology of Learning and Memory – 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    🧠 Learning & Memory (Cold Spring Harbor, N.Y.) – 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    🧠 The Journal of Neuroscience – 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    💊 The American Journal of Gastroenterology – 2011
    DOI: 10.1038/ajg.2011.179